Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Orally active and potent GH secretagogue discovered by Merck & Co.

June 18, 1998

Insulin sensitizer induces ovulation in women with PCOS

June 17, 1998

Beta3-adrenoceptor agonist CL-316243 enhances insulin activity in humans

June 17, 1998

Tetrahydrobenzo[a]fluorenes for postmenopausal symptoms and related disorders

June 17, 1998

Insulin sensitizers developed at JT with potent hypoglycemic effects

June 17, 1998

PTPase active-site modulators from Ontogen: a novel approach to treating diabetes

June 17, 1998

SDZ-WAG-994 useful for cardiovascular/metabolic complications in diabetes

June 17, 1998

TH-9506 achieves positive phase I results

June 16, 1998

DiavaX potential for vaccination against diabetes shown in preclinical models

June 16, 1998

Positive FDA preliminary review of Cenestin NDA

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...